Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail
Clinical trial NCT05358873 · COMPLETED
Trial details
- NCT number
- NCT05358873
- Sponsor
- Chulalongkorn University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2022-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.